MEGAN MENDELSON: Open Payments
NPI 1871070466 · ALBANY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$658 in 32 payments from 10 companies in 2025. Trend: 2023 $1,443 · 2024 $1,947 · 2025 $658
Food & beverage: $658
| Company | Payments | Amount |
|---|---|---|
| HEARTFLOW, INC. | 4 | $161 |
| Merck Sharp & Dohme LLC | 8 | $137 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $99 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 8 | $93 |
| Boston Scientific Corporation | 2 | $51 |
| Amgen Inc. | 2 | $34 |
| Novartis Pharmaceuticals Corporation | 1 | $24 |
| PFIZER INC. | 1 | $21 |
| BridgeBio Pharma, Inc. | 1 | $19 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
Products named: FFRct, VERQUVO, JARDIANCE, LifeVest, REPATHA, WATCHMAN FLX, LEQVIO, VYNDAQEL.
Industry payments across NY — which companies pay providers there.
